8-K: Intelligent Bio Solutions' Fingerprint Drug Testing Adopted by Quantum Traffic Management

Quantum Traffic Management, a UK-based traffic management provider, has adopted Intelligent Bio Solutions' fingerprint drug testing solution to improve workplace testing efficiency and safety across its 10 nationwide sites.

Summary

• Intelligent Bio Solutions Inc. (INBS) announced that Quantum Traffic Management (Quantum TM), a UK-based traffic management provider, has adopted INBS' Intelligent Fingerprinting Drug Testing Solution.
• Quantum TM will implement the solution across its 10 nationwide sites to enhance workplace testing efficiency and safety.
• Previously, Quantum TM used saliva and urine testing, which caused delays and inefficiencies.
• INBS' fingerprint sweat-based system allows Quantum TM to conduct on-the-spot drug screening in-house, leading to faster decision-making and improved operational efficiency.
• INBS has over 400 accounts across 19 countries and plans to enter the US market in 2025 following its recent FDA 510(k) submission in December 2024.
• The Intelligent Fingerprinting Drug Screening System screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis, with results available in under ten minutes.

Sentiment

Score: 7

Explanation: The announcement is positive, highlighting a new client adoption and expansion plans. However, the forward-looking statements and associated risks temper the overall sentiment.

Positives

• Quantum TM is implementing a more efficient and hygienic drug testing method.
• INBS' technology allows for rapid, on-site drug screening without specialized staff or facilities.
• INBS is expanding its market presence with plans to enter the US market in 2025.
• The Intelligent Fingerprinting Drug Screening System provides results in under ten minutes.

Risks

• The forward-looking statements in the release are subject to risks and uncertainties, including the ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals.
• The company's expectations may prove to be materially different from the results expressed or implied by the forward-looking statements.

Future Outlook

Intelligent Bio Solutions plans to enter the US market in 2025 and leverage the rapidly expanding global POC drug screening market.

Management Comments

• Scott Powell, Managing Director at Quantum TM, stated that the Intelligent Fingerprinting Drug Testing Solution provides greater control over drug testing and has already improved testing efficiency with rapid, non-invasive screening.

Industry Context

The announcement highlights the growing trend of companies seeking more efficient and convenient drug testing solutions, particularly in safety-critical industries. The move towards non-invasive, on-site testing aligns with the broader industry shift towards point-of-care diagnostics and improved workplace safety measures.

Comparison to Industry Standards

• Traditional drug testing methods, such as saliva and urine testing, often involve external occupational health providers, leading to delays and logistical challenges.
• Companies like Abbott and Roche offer rapid diagnostic solutions, but INBS' fingerprint-based approach offers a unique non-invasive alternative.
• Compared to competitors, INBS' system provides results in under ten minutes, potentially offering a faster turnaround time than some traditional methods.
• The adoption of INBS' solution by Quantum TM demonstrates a preference for in-house, rapid testing capabilities, aligning with the trend of companies seeking greater control over their drug screening processes.

Stakeholder Impact

• Shareholders may view the news positively as it indicates business growth and market expansion.
• Employees at Quantum TM benefit from a safer and more efficient workplace due to improved drug testing procedures.
• Customers of Quantum TM can expect enhanced safety and reliability in their services.
• Suppliers of INBS may see increased demand for their products and services.

Key Dates